AF488 Anti-Human CD95 Antibody[DX2]

AF488 Anti-Human CD95 Antibody[DX2]

Introducing the AF488 Anti-Human CD95 Antibody [DX2], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD95 antigen in human samples.

The AF488 Anti-Human CD95 Antibody [DX2] is meticulously engineered using cutting-edge technology, ensuring its superior performance and reliability. With its high affinity and selectivity, this antibody enables accurate and precise identification of CD95, a crucial cell surface receptor involved in various biological processes.

This product's AF488 labeling provides an added advantage, allowing for easy visualization and detection of CD95 expression in a wide range of experimental applications. Its exceptional fluorescence properties ensure bright and clear signals, facilitating efficient analysis and interpretation of results.

The AF488 Anti-Human CD95 Antibody [DX2] is manufactured under stringent quality control measures, guaranteeing consistent and reproducible results. Its exceptional stability and long shelf life ensure optimal performance throughout its usage, making it an ideal choice for both routine laboratory experiments and complex research studies.

Furthermore, this antibody has been extensively validated and proven to exhibit minimal cross-reactivity with other antigens, ensuring accurate and specific detection of CD95. Its compatibility with various techniques, including flow cytometry, immunofluorescence, and immunohistochemistry, further enhances its versatility and usability.

In summary, the AF488 Anti-Human CD95 Antibody [DX2] is a highly reliable and efficient tool for researchers and scientists seeking to explore the intricate mechanisms involving CD95. Its exceptional specificity, sensitivity, and compatibility with multiple techniques make it an invaluable asset in advancing scientific knowledge and understanding in the field.